Jamie Partridge, PhD, MBA, is a Senior Director of Global Market Access at Bayer Pharmaceuticals covering oncology therapeutics with a focus on health economics and outcomes research (HEOR). Jamie is also a Senior Lecturer of Health Administration at New York University’s Robert F. Wagner Graduate School of Public Service teaching health economics. Prior to Jamie’s current role in Global Market Access, she served as HEOR field liaison director covering the US Bayer pharmaceutical portfolio with a focus on US payers. Before joining Bayer, Jamie was Director, HEOR at Abbott’s Vascular and Nutrition divisions.
Prior to working in industry, Jamie was a researcher in the Center for Health Outcomes, Policy and Evaluation Studies in the College of Public Health at the Ohio State University and served as a faculty member at a variety of universities in the US and Canada.
Jamie’s research focus is in economics and healthcare with recent publications in PharmacoEconomics, American Health and Drug Benefits, and Advances in Therapy. Jamie has a B.A. in Economics from the University of Illinois, an M.B.A in Finance and Operations Management from Indiana University’s Kelley School of Business, and a Ph.D. in Agricultural Economics from the University of Saskatchewan.
Updated: September 2022